BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-034 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-034@nextconsensus.com
DTSTAMP:20261015T000000Z
DTSTART;VALUE=DATE:20261217
DTEND;VALUE=DATE:20261218
SUMMARY:FF-034 deadline: Relacorilant · Cushing's syndrome approval
DESCRIPTION:Registered forecast FF-034 (FDA)\, Relacorilant · Cushing's sy
 ndrome approval. It asks whether this happens by 2026-12-17. The record: h
 ttps://nextconsensus.com/forecast/ff-034/
URL:https://nextconsensus.com/forecast/ff-034/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR